Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1994 1
1995 3
1996 2
1997 1
1999 2
2000 2
2001 1
2002 4
2003 4
2004 6
2006 3
2007 1
2008 3
2009 6
2010 2
2011 3
2012 2
2013 4
2014 5
2015 4
2016 2
2017 2
2018 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Results by year
Filters applied: . Clear all
Page 1
Transglutaminase 2 in inflammation.
Kim SY. Kim SY. Front Biosci. 2006 Sep 1;11:3026-35. doi: 10.2741/2030. Front Biosci. 2006. PMID: 16720373 Review.
In most cases, TG 2 appears to form an inappropriate protein aggregate that may be cytotoxic enough to trigger inflammation and/or apoptosis. In some cases, such as celiac disease and rheumatoid arthritis, TG 2 is also associated with the pathogenic progression, as well as …
In most cases, TG 2 appears to form an inappropriate protein aggregate that may be cytotoxic enough to trigger inflammation and/or apoptosis …
Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion.
Raghu H, Cruz C, Rewerts CL, Frederick MD, Thornton S, Mullins ES, Schoenecker JG, Degen JL, Flick MJ. Raghu H, et al. Blood. 2015 Jan 15;125(3):427-37. doi: 10.1182/blood-2014-08-594754. Epub 2014 Oct 21. Blood. 2015. PMID: 25336631 Free PMC article.
Here, we demonstrate that the coagulation transglutaminase, factor XIII (fXIII), drives arthritis pathogenesis by promoting local inflammatory and tissue degradative and remodeling events. All pathological features of collagen-induced arthritis (CIA) were significan …
Here, we demonstrate that the coagulation transglutaminase, factor XIII (fXIII), drives arthritis pathogenesis by promoting local inf …
Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis: a reflection of the involvement of transglutaminase in coeliac disease.
Stenberg P, Roth B, Wollheim FA. Stenberg P, et al. Eur J Intern Med. 2009 Dec;20(8):749-55. doi: 10.1016/j.ejim.2009.08.007. Epub 2009 Sep 19. Eur J Intern Med. 2009. PMID: 19892302 Review.
Anti-TG2 has become a specific biomarker for CD. In rheumatoid arthritis (RA), the presence of antibodies against citrullinated peptides (ACPA) characterizes a distinct subset of this inflammatory disorder. ...
Anti-TG2 has become a specific biomarker for CD. In rheumatoid arthritis (RA), the presence of antibodies against citrullinated pepti …
Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
Luft LM, Barr SG, Martin LO, Chan EK, Fritzler MJ. Luft LM, et al. J Rheumatol. 2003 Dec;30(12):2613-9. J Rheumatol. 2003. PMID: 14719202
METHODS: Sera from 50 patients with SS, 50 with systemic lupus erythematosus (SLE), 50 with rheumatoid arthritis (RA), 30 with systemic sclerosis (SSc), and 50 healthy controls were tested for autoantibodies to tTG. ...
METHODS: Sera from 50 patients with SS, 50 with systemic lupus erythematosus (SLE), 50 with rheumatoid arthritis (RA), 30 with system …
Tissue transglutaminase enhances collagen type II-induced arthritis and modifies the immunodominant T-cell epitope CII260-270.
Dzhambazov B, Lindh I, Engström A, Holmdahl R. Dzhambazov B, et al. Eur J Immunol. 2009 Sep;39(9):2412-23. doi: 10.1002/eji.200939438. Eur J Immunol. 2009. PMID: 19676074 Free article.
In this study, we have investigated the impact of tTG for posttranslational modifications and cross-linking of the immunodominant T-cell epitope CII260-270 and their effects on the collagen-induced arthritis, an animal model for rheumatoid arthritis. By using mass s …
In this study, we have investigated the impact of tTG for posttranslational modifications and cross-linking of the immunodominant T-cell epi …
Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis.
Riente L, Chimenti D, Pratesi F, Delle Sedie A, Tommasi S, Tommasi C, Bombardieri S, Migliorini P. Riente L, et al. J Rheumatol. 2004 May;31(5):920-4. J Rheumatol. 2004. PMID: 15124251
OBJECTIVE: Subclinical gut inflammation has been described in patients with ankylosing spondylitis (AS) or psoriatic arthritis (PsA). Joint involvement has also been reported related to celiac disease. ...As control groups we considered 79 patients with rheumatoid arthr
OBJECTIVE: Subclinical gut inflammation has been described in patients with ankylosing spondylitis (AS) or psoriatic arthritis (PsA). …
56 results